Search Within

Nabeela Ali Khan

Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
Groups
  1. Department of Medicine (14)
  2. Genitourinary Oncology Service (14)
  3. Sloan Kettering Institute Postdocs (14)
  4. Solid Tumor Oncology Division (14)
  5. Human Oncology and Pathogenesis Program (5)
  6. GSK Faculty (4)

More Groups

People
  1. Philip Kantoff (12)
  2. Goutam Chakraborty (10)
  3. Mohammad Atiq (10)
  4. Ying Mazzu (10)
  5. Yuki Yoshikawa (10)
  6. Subhiksha Nandakumar (8)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (7)
  4. 2018 (3)
  5. 2017 (1)
  6. 2016 (1)
Publications
  1. Cancer Research (4)
  2. Clinical Cancer Research (3)
  3. Journal of Clinical Oncology (3)
  4. BJU International (1)
  5. Cancer Epidemiology Biomarkers and Prevention (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (1)
  4. FEBS Press (1)
  5. Wiley Blackwell (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis of metastatic non–clear-cell renal cell carcinoma to identify therapeutic targets
    Journal Article

    Carlo, M. I.; Khan, N.; Zehir, A.; Patil, S.; Ged, Y.; Redzematovic, A.; Coskey, D. T.; Hyman, D. M.; Ladanyi, M.; Chen, Y. B.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Targeting checkpoint kinases in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Jehane, L. E.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Combination treatment of PARP and SRC inhibitors in BRCA2 mutated prostate cancer
    Meeting Abstract

    Khan, N.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Atiq, M.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Meeting Abstract

    Atiq, M.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer
    Meeting Abstract

    Chakraborty, G.; Atiq, M.; Nandakumar, S.; Mazzu, Y. Z.; Armenia, J.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Coggins, S. A.; Nandakumar, S.; Gerke, T. A.; Pomerantz, M. M.; Qiu, X.; Zhao, H.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Intratumoral sterol-27-hydroxylase (CYP27A1) expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer
    Journal Article

    Khan, N. A.; Stopsack, K. H.; Allott, E. H.; Gerke, T.; Giovannucci, E. L.; Mucci, L. A.; Kantoff, P. W.
    Cancer Epidemiology Biomarkers and Prevention (2019)

    Fulltext@MSK | Save